Back to User profile » Prof. Dr. Edoardo Vincenzo Savarino
Papers published by Prof. Dr. Edoardo Vincenzo Savarino:
The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management
Bertin L, Caldart F, Barchi A, Seregni N, Pasta A, Calabrese F, Marabotto E, Mari A, Farah A, Sirinic E, Sorge A, Ghisa M, Chahuán J, Savarino V, Savarino EV
ImmunoTargets and Therapy 2026, 15:510865
Published Date: 27 May 2026
Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations
Bertin L, Crepaldi M, Zanconato M, Lorenzon G, Maniero D, De Barba C, Bonazzi E, Facchin S, Scarpa M, Ruffolo C, Angriman I, Buda A, Zingone F, Savarino EV, Barberio B
Clinical and Experimental Gastroenterology 2024, 17:261-315
Published Date: 10 October 2024
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes
Visaggi P, Ghisa M, Vespa E, Barchi A, Mari A, Pasta A, Marabotto E, de Bortoli N, Savarino EV
ImmunoTargets and Therapy 2024, 13:367-383
Published Date: 24 July 2024
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E
Drug Design, Development and Therapy 2021, 15:1609-1621
Published Date: 19 April 2021
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
Marabotto E, Ziola S, Savarino V, Giannini EG, Furnari M, Bodini G, Zingone F, Ghisa M, Barberio B, Zentilin P, Savarino E
Clinical and Experimental Gastroenterology 2020, 13:99-104
Published Date: 15 April 2020
Idiopathic pulmonary fibrosis and GERD: links and risks
Ghisa M, Marinelli C, Savarino V, Savarino E
Therapeutics and Clinical Risk Management 2019, 15:1081-1093
Published Date: 5 September 2019